Prof. Erik Stroes, Amsterdam, The Netherlands, provided an overview on the importance of cascade screening to detect Famiial Hypercholesterolemia (FH) and the lifetime benefits of early initiation of therapy. The introduction was followed by discussion with the EPCCS board and council members representing primary care from multiple European countries.
Introduction: FH is a common inhereted condition 00:12
Early initiation of therapy 03:18
Choosing the most effective screening for FH 06:18
Audience discussion 06:57Prof. Erik Stroes, department of Vascular Medicine, AmsterdamUMC, The Netherlands
The Amsterdam UMC is globally recognized as a pioneer and "frontrunner" in the screening, diagnosis, and treatment of FH. Their expertise is largely rooted in the Netherlands' historical success with national screening programs and their ongoing leadership in "cascade screening".
The EPCCS Annual Cardiovascular Summit is designed to provide a dynamic platform for exchange between specialists and primary care professionals from across Europe. By bringing together diverse clinical perspectives, the summit aims to translate high-level cardiovascular research into practical, actionable strategies for the primary care setting, ultimately improving patient outcomes across the continent.
